Imaging the accumulation and suppression of tau pathology using multiparametric MRI
Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic reso...
Gespeichert in:
Veröffentlicht in: | Neurobiology of aging 2016-03, Vol.39, p.184-194 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 194 |
---|---|
container_issue | |
container_start_page | 184 |
container_title | Neurobiology of aging |
container_volume | 39 |
creator | Holmes, Holly E Colgan, Niall Ismail, Ozama Ma, Da Powell, Nick M O'Callaghan, James M Harrison, Ian F Johnson, Ross A Murray, Tracey K Ahmed, Zeshan Heggenes, Morton Fisher, Alice Cardoso, M.J Modat, Marc Walker-Samuel, Simon Fisher, Elizabeth M.C Ourselin, Sebastien O'Neill, Michael J Wells, Jack A Collins, Emily C Lythgoe, Mark F |
description | Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes. |
doi_str_mv | 10.1016/j.neurobiolaging.2015.12.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4782737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0197458015006053</els_id><sourcerecordid>1790946103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxS0EokvhK6AcOHBJsBP_lVAlVLWwUhEShbPlOJNdL0kc7LjSfnsctlSUEyeP5ffeWPMbhN4QXBFM-LtDNUEKvnV-MDs37aoaE1aRusKYPEEbwpgsCVXiKdpgokRJmcRn6EWMB4yxoII_R2c1V3VDCdug2-34O6VY9lAYa9OYBrM4PxVm6oqY5jlAjOvd98ViUjGbZe8HvzsWKa6-rF_cbIIZYQnOFp-_bl-iZ70ZIry6P8_R9-urb5efypsvH7eXH25Ky6laSgZ1hynvbSNky3vMCGsp47Jra0kF6XIFHVEUGqmosEy2zEjWSQGGK4Vpc44uTrlzakfoLExLMIOegxtNOGpvnH78Mrm93vk7TYWsRSNywNv7gOB_JoiLHl20MAxmAp-iJkJhRTnBTZa-P0lt8DEG6B_aEKxXLvqgH3PRKxdNap25ZPvrv7_6YP4DIguuTwLIA7tzEHS0DiYLnQtgF91597-dLv4JsoObnDXDDzhCPPgUpgxFEx2zQd-uO7KuCGEYc8ya5hfGk75R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790946103</pqid></control><display><type>article</type><title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Holmes, Holly E ; Colgan, Niall ; Ismail, Ozama ; Ma, Da ; Powell, Nick M ; O'Callaghan, James M ; Harrison, Ian F ; Johnson, Ross A ; Murray, Tracey K ; Ahmed, Zeshan ; Heggenes, Morton ; Fisher, Alice ; Cardoso, M.J ; Modat, Marc ; Walker-Samuel, Simon ; Fisher, Elizabeth M.C ; Ourselin, Sebastien ; O'Neill, Michael J ; Wells, Jack A ; Collins, Emily C ; Lythgoe, Mark F</creator><creatorcontrib>Holmes, Holly E ; Colgan, Niall ; Ismail, Ozama ; Ma, Da ; Powell, Nick M ; O'Callaghan, James M ; Harrison, Ian F ; Johnson, Ross A ; Murray, Tracey K ; Ahmed, Zeshan ; Heggenes, Morton ; Fisher, Alice ; Cardoso, M.J ; Modat, Marc ; Walker-Samuel, Simon ; Fisher, Elizabeth M.C ; Ourselin, Sebastien ; O'Neill, Michael J ; Wells, Jack A ; Collins, Emily C ; Lythgoe, Mark F</creatorcontrib><description>Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes.</description><identifier>ISSN: 0197-4580</identifier><identifier>EISSN: 1558-1497</identifier><identifier>DOI: 10.1016/j.neurobiolaging.2015.12.001</identifier><identifier>PMID: 26923415</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease - metabolism ; Alzheimer Disease - pathology ; Alzheimer's disease ; Animals ; Atrophy - genetics ; Biomarker ; Cerebral Cortex - pathology ; Disease Models, Animal ; Doxycycline - pharmacology ; Female ; Hippocampus - pathology ; Internal Medicine ; In vivo ; Longitudinal ; Longitudinal Studies ; Magnetic Resonance Imaging - methods ; Male ; Mice, Transgenic ; MRI ; Neurofibrillary Tangles - pathology ; Neurology ; Regular ; tau Proteins - genetics ; tau Proteins - metabolism ; Tauopathies - pathology ; Tauopathy ; Transgenes - drug effects</subject><ispartof>Neurobiology of aging, 2016-03, Vol.39, p.184-194</ispartof><rights>The Authors</rights><rights>2016 The Authors</rights><rights>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>2016 The Authors 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</citedby><cites>FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0197458015006053$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26923415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holmes, Holly E</creatorcontrib><creatorcontrib>Colgan, Niall</creatorcontrib><creatorcontrib>Ismail, Ozama</creatorcontrib><creatorcontrib>Ma, Da</creatorcontrib><creatorcontrib>Powell, Nick M</creatorcontrib><creatorcontrib>O'Callaghan, James M</creatorcontrib><creatorcontrib>Harrison, Ian F</creatorcontrib><creatorcontrib>Johnson, Ross A</creatorcontrib><creatorcontrib>Murray, Tracey K</creatorcontrib><creatorcontrib>Ahmed, Zeshan</creatorcontrib><creatorcontrib>Heggenes, Morton</creatorcontrib><creatorcontrib>Fisher, Alice</creatorcontrib><creatorcontrib>Cardoso, M.J</creatorcontrib><creatorcontrib>Modat, Marc</creatorcontrib><creatorcontrib>Walker-Samuel, Simon</creatorcontrib><creatorcontrib>Fisher, Elizabeth M.C</creatorcontrib><creatorcontrib>Ourselin, Sebastien</creatorcontrib><creatorcontrib>O'Neill, Michael J</creatorcontrib><creatorcontrib>Wells, Jack A</creatorcontrib><creatorcontrib>Collins, Emily C</creatorcontrib><creatorcontrib>Lythgoe, Mark F</creatorcontrib><title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</title><title>Neurobiology of aging</title><addtitle>Neurobiol Aging</addtitle><description>Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes.</description><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Atrophy - genetics</subject><subject>Biomarker</subject><subject>Cerebral Cortex - pathology</subject><subject>Disease Models, Animal</subject><subject>Doxycycline - pharmacology</subject><subject>Female</subject><subject>Hippocampus - pathology</subject><subject>Internal Medicine</subject><subject>In vivo</subject><subject>Longitudinal</subject><subject>Longitudinal Studies</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Mice, Transgenic</subject><subject>MRI</subject><subject>Neurofibrillary Tangles - pathology</subject><subject>Neurology</subject><subject>Regular</subject><subject>tau Proteins - genetics</subject><subject>tau Proteins - metabolism</subject><subject>Tauopathies - pathology</subject><subject>Tauopathy</subject><subject>Transgenes - drug effects</subject><issn>0197-4580</issn><issn>1558-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxS0EokvhK6AcOHBJsBP_lVAlVLWwUhEShbPlOJNdL0kc7LjSfnsctlSUEyeP5ffeWPMbhN4QXBFM-LtDNUEKvnV-MDs37aoaE1aRusKYPEEbwpgsCVXiKdpgokRJmcRn6EWMB4yxoII_R2c1V3VDCdug2-34O6VY9lAYa9OYBrM4PxVm6oqY5jlAjOvd98ViUjGbZe8HvzsWKa6-rF_cbIIZYQnOFp-_bl-iZ70ZIry6P8_R9-urb5efypsvH7eXH25Ky6laSgZ1hynvbSNky3vMCGsp47Jra0kF6XIFHVEUGqmosEy2zEjWSQGGK4Vpc44uTrlzakfoLExLMIOegxtNOGpvnH78Mrm93vk7TYWsRSNywNv7gOB_JoiLHl20MAxmAp-iJkJhRTnBTZa-P0lt8DEG6B_aEKxXLvqgH3PRKxdNap25ZPvrv7_6YP4DIguuTwLIA7tzEHS0DiYLnQtgF91597-dLv4JsoObnDXDDzhCPPgUpgxFEx2zQd-uO7KuCGEYc8ya5hfGk75R</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Holmes, Holly E</creator><creator>Colgan, Niall</creator><creator>Ismail, Ozama</creator><creator>Ma, Da</creator><creator>Powell, Nick M</creator><creator>O'Callaghan, James M</creator><creator>Harrison, Ian F</creator><creator>Johnson, Ross A</creator><creator>Murray, Tracey K</creator><creator>Ahmed, Zeshan</creator><creator>Heggenes, Morton</creator><creator>Fisher, Alice</creator><creator>Cardoso, M.J</creator><creator>Modat, Marc</creator><creator>Walker-Samuel, Simon</creator><creator>Fisher, Elizabeth M.C</creator><creator>Ourselin, Sebastien</creator><creator>O'Neill, Michael J</creator><creator>Wells, Jack A</creator><creator>Collins, Emily C</creator><creator>Lythgoe, Mark F</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20160301</creationdate><title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</title><author>Holmes, Holly E ; Colgan, Niall ; Ismail, Ozama ; Ma, Da ; Powell, Nick M ; O'Callaghan, James M ; Harrison, Ian F ; Johnson, Ross A ; Murray, Tracey K ; Ahmed, Zeshan ; Heggenes, Morton ; Fisher, Alice ; Cardoso, M.J ; Modat, Marc ; Walker-Samuel, Simon ; Fisher, Elizabeth M.C ; Ourselin, Sebastien ; O'Neill, Michael J ; Wells, Jack A ; Collins, Emily C ; Lythgoe, Mark F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Atrophy - genetics</topic><topic>Biomarker</topic><topic>Cerebral Cortex - pathology</topic><topic>Disease Models, Animal</topic><topic>Doxycycline - pharmacology</topic><topic>Female</topic><topic>Hippocampus - pathology</topic><topic>Internal Medicine</topic><topic>In vivo</topic><topic>Longitudinal</topic><topic>Longitudinal Studies</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Mice, Transgenic</topic><topic>MRI</topic><topic>Neurofibrillary Tangles - pathology</topic><topic>Neurology</topic><topic>Regular</topic><topic>tau Proteins - genetics</topic><topic>tau Proteins - metabolism</topic><topic>Tauopathies - pathology</topic><topic>Tauopathy</topic><topic>Transgenes - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holmes, Holly E</creatorcontrib><creatorcontrib>Colgan, Niall</creatorcontrib><creatorcontrib>Ismail, Ozama</creatorcontrib><creatorcontrib>Ma, Da</creatorcontrib><creatorcontrib>Powell, Nick M</creatorcontrib><creatorcontrib>O'Callaghan, James M</creatorcontrib><creatorcontrib>Harrison, Ian F</creatorcontrib><creatorcontrib>Johnson, Ross A</creatorcontrib><creatorcontrib>Murray, Tracey K</creatorcontrib><creatorcontrib>Ahmed, Zeshan</creatorcontrib><creatorcontrib>Heggenes, Morton</creatorcontrib><creatorcontrib>Fisher, Alice</creatorcontrib><creatorcontrib>Cardoso, M.J</creatorcontrib><creatorcontrib>Modat, Marc</creatorcontrib><creatorcontrib>Walker-Samuel, Simon</creatorcontrib><creatorcontrib>Fisher, Elizabeth M.C</creatorcontrib><creatorcontrib>Ourselin, Sebastien</creatorcontrib><creatorcontrib>O'Neill, Michael J</creatorcontrib><creatorcontrib>Wells, Jack A</creatorcontrib><creatorcontrib>Collins, Emily C</creatorcontrib><creatorcontrib>Lythgoe, Mark F</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurobiology of aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holmes, Holly E</au><au>Colgan, Niall</au><au>Ismail, Ozama</au><au>Ma, Da</au><au>Powell, Nick M</au><au>O'Callaghan, James M</au><au>Harrison, Ian F</au><au>Johnson, Ross A</au><au>Murray, Tracey K</au><au>Ahmed, Zeshan</au><au>Heggenes, Morton</au><au>Fisher, Alice</au><au>Cardoso, M.J</au><au>Modat, Marc</au><au>Walker-Samuel, Simon</au><au>Fisher, Elizabeth M.C</au><au>Ourselin, Sebastien</au><au>O'Neill, Michael J</au><au>Wells, Jack A</au><au>Collins, Emily C</au><au>Lythgoe, Mark F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</atitle><jtitle>Neurobiology of aging</jtitle><addtitle>Neurobiol Aging</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>39</volume><spage>184</spage><epage>194</epage><pages>184-194</pages><issn>0197-4580</issn><eissn>1558-1497</eissn><abstract>Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26923415</pmid><doi>10.1016/j.neurobiolaging.2015.12.001</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0197-4580 |
ispartof | Neurobiology of aging, 2016-03, Vol.39, p.184-194 |
issn | 0197-4580 1558-1497 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4782737 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Alzheimer Disease - metabolism Alzheimer Disease - pathology Alzheimer's disease Animals Atrophy - genetics Biomarker Cerebral Cortex - pathology Disease Models, Animal Doxycycline - pharmacology Female Hippocampus - pathology Internal Medicine In vivo Longitudinal Longitudinal Studies Magnetic Resonance Imaging - methods Male Mice, Transgenic MRI Neurofibrillary Tangles - pathology Neurology Regular tau Proteins - genetics tau Proteins - metabolism Tauopathies - pathology Tauopathy Transgenes - drug effects |
title | Imaging the accumulation and suppression of tau pathology using multiparametric MRI |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T12%3A15%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imaging%20the%20accumulation%20and%20suppression%20of%20tau%20pathology%20using%20multiparametric%20MRI&rft.jtitle=Neurobiology%20of%20aging&rft.au=Holmes,%20Holly%20E&rft.date=2016-03-01&rft.volume=39&rft.spage=184&rft.epage=194&rft.pages=184-194&rft.issn=0197-4580&rft.eissn=1558-1497&rft_id=info:doi/10.1016/j.neurobiolaging.2015.12.001&rft_dat=%3Cproquest_pubme%3E1790946103%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1790946103&rft_id=info:pmid/26923415&rft_els_id=S0197458015006053&rfr_iscdi=true |